Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekkehard Sturm

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|April 30, 2021
Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B MutationsMichael W Hess, Iris M Krainer, Przemyslaw A Filipek, et al.
Gastroenterology|August 10, 2004
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11Saskia W C van Mil, Wendy L van der Woerd, Gerda van der Brugge, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Journal of Inherited Metabolic Disease|May 20, 2025
Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency (DLDD): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 PatientsNicole Hammann, Christian Staufner, Lea Dewi Schlieben, et al.
Lancet (London, England)|November 10, 2021
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 studyEmmanuel Gonzales, Winita Hardikar, Michael Stormon, et al.
Journal of Clinical Medicine|April 23, 2022
Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver ReplacementJean de Ville de Goyet, Toni Illhardt, Christophe Chardot, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 17, 2023
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in EuropeDominic Lenz, Marianne Hørby Jørgensen, Deirdre Kelly, et al.
The Lancet. Gastroenterology & Hepatology|April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialNadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Transplantation|May 5, 2023
Long-term Outcome of Asymptomatic Patients With Graft Fibrosis in Protocol Biopsies After Pediatric Liver TransplantationSteffen Hartleif, James Hodson, Carla Lloyd, et al.
The Lancet. Gastroenterology & Hepatology|July 5, 2022
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|April 30, 2021
Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B MutationsMichael W Hess, Iris M Krainer, Przemyslaw A Filipek, et al.
Gastroenterology|August 10, 2004
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11Saskia W C van Mil, Wendy L van der Woerd, Gerda van der Brugge, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Journal of Inherited Metabolic Disease|May 20, 2025
Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency (DLDD): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 PatientsNicole Hammann, Christian Staufner, Lea Dewi Schlieben, et al.
Lancet (London, England)|November 10, 2021
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 studyEmmanuel Gonzales, Winita Hardikar, Michael Stormon, et al.
Journal of Clinical Medicine|April 23, 2022
Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver ReplacementJean de Ville de Goyet, Toni Illhardt, Christophe Chardot, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 17, 2023
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in EuropeDominic Lenz, Marianne Hørby Jørgensen, Deirdre Kelly, et al.
The Lancet. Gastroenterology & Hepatology|April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trialNadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Transplantation|May 5, 2023
Long-term Outcome of Asymptomatic Patients With Graft Fibrosis in Protocol Biopsies After Pediatric Liver TransplantationSteffen Hartleif, James Hodson, Carla Lloyd, et al.
The Lancet. Gastroenterology & Hepatology|July 5, 2022
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trialRichard J Thompson, Henrik Arnell, Reha Artan, et al.
Pageof 7